Literature DB >> 23165404

Bladder cancer: Lack of progress in bladder cancer--what are the obstacles?

Mark S Soloway1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23165404     DOI： 10.1038/nrurol.2012.219

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  7 in total

1.  Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?

Authors:  H W Herr
Journal:  BJU Int       Date:  2001-11       Impact factor: 5.588

2.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

3.  Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Authors:  Mark S Soloway; Darren S Bruck; Sandy S Kim
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

4.  Superficial bladder cancer: progression and recurrence.

Authors:  N M Heney; S Ahmed; M J Flanagan; W Frable; M P Corder; M D Hafermann; I R Hawkins
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

5.  Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology.

Authors:  Yair Lotan; Ashish M Kamat; Michael P Porter; Victoria L Robinson; Neal Shore; Michael Jewett; Paul F Schelhammer; Ralph deVere White; Diane Quale; Cheryl T Lee
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

Review 6.  Demographic analysis of randomized controlled trials in bladder cancer.

Authors:  Bassel G Bachir; Shahrokh F Shariat; Alexandre Zlotta; Robert Svatek; Peter C Black; Jay B Shah; Wassim Kassouf
Journal:  BJU Int       Date:  2012-08-29       Impact factor: 5.588

Review 7.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta
Journal:  Eur Urol       Date:  2008-04-30       Impact factor: 20.096
  7 in total
  30 in total

Review 1.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

2.  Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells.

Authors:  Jiaxi Yao; Yue Liu; Jitao Yang; Mengling Li; Simin Li; Bo Zhang; Rui Yang; Yuchong Zhang; Xiaoyu Cui; ChunQing Feng
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

3.  Study on Molecular Information Intelligent Diagnosis and Treatment of Bladder Cancer on Pathological Tissue Image.

Authors:  Yanfeng Bai; Huogen Wang; Xuesong Wu; Menghan Weng; Qingmei Han; Liming Xu; Han Zhang; Chengdong Chang; Chaohui Jin; Ming Chen; Kunfeng Luo; Xiaodong Teng
Journal:  Front Med (Lausanne)       Date:  2022-06-03

4.  Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

Authors:  Linfeng Zheng; Yuping Zhu; Lei Lei; Wenyong Sun; Guoping Cheng; Shifeng Yang
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

5.  PPM-18, an Analog of Vitamin K, Induces Autophagy and Apoptosis in Bladder Cancer Cells Through ROS and AMPK Signaling Pathways.

Authors:  Huiai Lu; Chunlei Mei; Luhao Yang; Junyan Zheng; Junwei Tong; Fengsen Duan; Huageng Liang; Ling Hong
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 6.  Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.

Authors:  Masayoshi Nagata; Satoru Muto; Shigeo Horie
Journal:  Dis Markers       Date:  2016-01-26       Impact factor: 3.434

7.  The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.

Authors:  Chong Li; Song Wu; Haifeng Wang; Xingang Bi; Zhao Yang; Ying Du; Luyun He; Zhiming Cai; Jiansong Wang; Zusen Fan
Journal:  Oncotarget       Date:  2015-08-14

8.  Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.

Authors:  Miriam Gross-Cohen; Sari Feld; Inna Naroditsky; Ofer Nativ; Neta Ilan; Israel Vlodavsky
Journal:  Oncotarget       Date:  2016-04-19

9.  The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN.

Authors:  Hiroshi Egawa; Kentaro Jingushi; Takayuki Hirono; Yuko Ueda; Kaori Kitae; Wataru Nakata; Kazutoshi Fujita; Motohide Uemura; Norio Nonomura; Kazutake Tsujikawa
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

10.  Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer.

Authors:  Lin-Feng Zheng; Wen-Yong Sun
Journal:  Biomed Rep       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.